9951035OCR.pdf (2.78 MB)
Selective matrix metalloproteinase inhibitors
standard
posted on 2018-08-07, 00:00 authored by Mayland ChangMayland Chang, Shahriar MobasheryShahriar MobasheryThe invention provides compounds, compositions, and methods for the treatment of diseases, disorders, or conditions that are modulated by matrix metalloproteinases (MMPs). The compounds can be selective MMP inhibitors, for example, selective inhibitors of MMP-2, MMP-9, and/or MMP-14. The disease, disorder, or condition can include, for example, stroke, neurological disorders, ophthalmological disorders, or wounds, such as chronic wounds or diabetic wounds.
History
Patent Number
US 9951035 B2Other Application
15/469,010Inventor
Mayland Chang Shahriar MobasheryInventor from Local Institution
Mayland Chang Shahriar MobasheryAssignee
University of Notre Dame Du LacDate Modified
2018-08-07Language
- English
Claims
19Prior Publication Number
US 20170190685 A1Publisher
U.S. Patent and Trademark OfficeCooperative Patent Classification Codes
C07D 413/12 (20130101); C07D 331/02 (20130101); A61K 9/0014 (20130101); A61K 31/38 (20130101); A61K 31/4245 (20130101); C07D 303/34 (20130101)Contributor
Mayland Chang|Shahriar MobasheryInternational Patent Classification Codes
C07D 331/02 (20060101); A61K 9/00 (20060101); A61K 31/38 (20060101); C07D 413/12 (20060101); C07D 303/34 (20060101); A61K 31/4245 (20060101)Usage metrics
Categories
No categories selectedKeywords
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC